Overview
BeauBrain Healthcare envisions a world free from the fear of dementia. The company is developing an artificial intelligence (AI) program to predict ATN biomarkers for early diagnosis of dementia, as well as digital therapeutics (DTx) for preventing and treating the disease. Their ultimate goal is to become a leader in precision medicine for dementia by creating a platform for brain health management. BeauBrain Healthcare offers integrated solutions encompassing digital cognitive assessments, AI-powered brain imaging analysis, cognitive training, and blood biomarker algorithms. The company’s platform utilizes a suite of cognitive tests and brain imaging scans to predict the risk of developing Alzheimer’s and other forms of dementia by analyzing brain activity and structure, identifying subtle changes before symptoms appear. This enables healthcare professionals to take proactive steps to delay or prevent the onset of cognitive decline, such as personalized cognitive training programs and lifestyle modifications.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered brain MRI analysis
- Automatic labeling, visualization, and volumetric quantification of brain structures
- Quantitative assessments of brain structure volumes
- Comparison to reference percentile data
- Supports clinical decision-making for neurodegeneration
- Utilizes deep learning algorithms
- Cloud-based deployment option
- Predicts ATN biomarkers for early dementia diagnosis
- Offers personalized cognitive training programs
- Processes 2D MRI scans
Use Cases
- Early diagnosis of Alzheimer's disease and other dementias
- Prediction of ATN biomarkers
- Monitoring of neurodegeneration through brain volume changes
- Supporting clinical decisions in radiology and neurology settings
- Personalized cognitive training for prevention and treatment
- Analyzing brain activity and structure to identify early changes
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud-based (SaaS) or on-premise |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Geriatrics, Neurology, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2026-05-13 | K260032 510(k) | Morph |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Morph
No FAQs available yet for this tool.





